Influence of payer coverage and out‐of‐pocket costs on ordering of NGS panel tests for hereditary cancer in diverse settings-Reference-Cited by-同舟云学术

Influence of payer coverage and out‐of‐pocket costs on ordering of NGS panel tests for hereditary cancer in diverse settings

Published:2021-07-07 Issue:1 Volume:31 Page:130-139
ISSN:1059-7700
Container-title:Journal of Genetic Counseling
language:en
Short-container-title:Journal of Genetic Counseling

Author:

Lin Grace A.¹²³^ORCID,Trosman Julia R.³⁴,Douglas Michael P.³,Weldon Christine B.⁴,Scheuner Maren T.²³⁵,Kurian Allison⁶,Phillips Kathryn A.²³⁵

Affiliation:

1. Department of Medicine University of California San Francisco CA USA

2. Philip R. Lee Institute for Health Policy Studies University of California San Francisco CA USA

3. Department of Clinical Pharmacy Center for Translational and Policy Research on Personalized Medicine (TRANSPERS) University of California‐San Francisco San Francisco CA USA

4. Center for Business Models in Healthcare Glencoe IL USA

5. UCSF Helen Diller Family Comprehensive Cancer Center University of California San Francisco CA USA

6. Departments of Medicine and of Epidemiology and Population Health Stanford University Stanford CA USA

Funder

National Cancer Institute

National Human Genome Research Institute

Publisher

Wiley

Subject

Genetics (clinical)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jgc4.1459

Reference22 articles.

1. Prevalence of mutations in a diverse cohort of 3162 women tested via the same multigene cancer panel in a managed care health plan

2. Using thematic analysis in psychology

3. NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020

4. The composition and capacity of the clinical genetics workforce in high-income countries: a scoping review

5. Financial barriers in a county genetics clinic: Problems and solutions

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sociodemographic and Clinical Characteristics Associated with Genetic Testing among Cancer Survivors: Evidence from Three Cancer Registries;Public Health Genomics;2024-08-05

2. Associations between subjective social status and predictors of interest in genetic testing among women diagnosed with breast cancer at a young age;Cancer Causes & Control;2024-05-03

3. The Role of Demographic and Clinical Factors in Germline Mutation Testing for Patients with Primary Hyperparathyroidism;Annals of Surgical Oncology;2024-03-08

4. Biomarker Testing, Targeted Therapy and Clinical Trial Participation by Race Among Patients With Lung Cancer: A Real-World Medicaid Database Study;JTO Clinical and Research Reports;2024-03

5. Safety Aspects of Herb Interactions: Current Understanding and Future Prospects;Current Drug Metabolism;2024-01